Similar to the results obtained by apoptosis assay, the combination of BMS-911543 and TKIs has significantly less toxicity on CD34+ NBM cells than CD34+ CML cells (n=4, P<0.0001, Supplementary Fig. 1B). The gene discussed is CD34; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.